Safe Handling of Hazardous Drugs

5. Creating an exposure control plan
In the Regulation
Workplaces where
cytotoxic drugs are
present must have an
exposure control plan
in place. See sections
5.54(1) and 6.43 of
the Regulation.
The employer must
review the exposure
control plan at least
annually and update
if required. See
section 5.54(3) of the
Regulation.
In the Regulation
Where cytotoxic
drugs are present in
the workplace, the
exposure control
plan for the must be
periodically reviewed.
See section 5.54 of
the Regulation.
An exposure control plan (ECP) describes how workers will be
protected from hazardous drugs in the workplace. An ECP includes
information on the nature of the hazard and the risk associated with
exposure, as well as controls that the employer will use to protect
workers.
The ECP includes the following components, which are detailed in
section 5.54(2) of the Regulation:
••
Statement of purpose and responsibilities
••
Risk identification and assessment
••
Risk controls
••
Written safe work procedures
••
Education and training
••
Written records
••
Hygiene facilities and decontamination procedures (when
required)
••
Health monitoring (when required)
The ECP should be reviewed at least annually and updated as
necessary by the employer, in consultation with the joint
occupational health and safety committee or the worker health and
safety representative.
10
Best Practices for the Safe Handling of Hazardous Drugs